Efficacy of Azithromycin 1% in the Clinical Management of Bacterial Conjunctivitis.

AIM: To evaluate the clinical efficacy and safety of topical azithromycin 1% ophthalmic preparation in bacterial conjunctivitis.

MATERIALS AND

METHODS

A prospective observational study was conducted on 150 patients clinically diagnosed with bacterial conjunctivitis and treated with topical azithromycin 1%. Clinical response and adverse events were assessed during follow-up.

RESULTS

High clinical cure rates were observed with minimal adverse effects, indicating good efficacy and tolerability.

CONCLUSION

Topical azithromycin 1% is a safe and effective treatment option for bacterial conjunctivitis in routine clinical practice.